Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Completed · Not applicable

Conditions studied: Opioid-use Disorder, Opioid Withdrawal

In brief

The objective of this study is to evaluate whether tAN via the tragus (vagal) and auriculotemporal (trigeminal) nerve pathways results in a clinically meaningful reduction in opioid withdrawal symptoms.

Key facts

Study ID
NCT04731935
Run by
Spark Biomedical, Inc.
People needed
6
Starts
2021-03-18
Expected to finish
2021-05-26
Last updated by the study team
2021-08-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.